Introduction Pharma tenders have evolved; they’re not just about the lowest price anymore. Hospitals, governmen...
Introduction A significant portion of the highest-value and highest-risk products in pharmaceutical manufacturing is...
Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...
Introduction Latin America is continuously evolving and growing in the field of pharmaceuticals. Due to the increasin...
Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...
The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...
Quick intro Global pharma buyers generally source their generic APIs from India and China due to their vast productio...
Introduction The pharmaceutical industry in the CIS (Commonwealth of Independent States) and Eastern Europe is develo...
The CIS and Eastern Europe are gradually turning into one of the world's most important markets for multinational ph...
Stay updated on pharma trends and marketplace opportunities.